406 related articles for article (PubMed ID: 27510483)
1. Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.
Muscogiuri G; Palomba S; Laganà AS; Orio F
Curr Pharm Des; 2016; 22(36):5554-5557. PubMed ID: 27510483
[TBL] [Abstract][Full Text] [Related]
2. Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome.
Cincione IR; Graziadio C; Marino F; Vetrani C; Losavio F; Savastano S; Colao A; Laudisio D
J Endocrinol Invest; 2023 Apr; 46(4):769-777. PubMed ID: 36401759
[TBL] [Abstract][Full Text] [Related]
3. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Gateva A; Unfer V; Kamenov Z
Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
5. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
Pizzo A; Laganà AS; Barbaro L
Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
[TBL] [Abstract][Full Text] [Related]
6. Myo-inositol vs. D-chiro inositol in PCOS treatment.
Formuso C; Stracquadanio M; Ciotta L
Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222
[TBL] [Abstract][Full Text] [Related]
7. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
Unfer V; Porcaro G
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
[TBL] [Abstract][Full Text] [Related]
8. High Fat Diet and Polycystic Ovary Syndrome (PCOS) in Adolescence: An Overview of Nutritional Strategies.
Calcaterra V; Magenes VC; Massini G; De Sanctis L; Fabiano V; Zuccotti G
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612972
[TBL] [Abstract][Full Text] [Related]
9. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
[TBL] [Abstract][Full Text] [Related]
10. Current treatment for polycystic ovary syndrome: focus on adolescence.
Street ME; Cirillo F; Catellani C; Dauriz M; Lazzeroni P; Sartori C; Moghetti P
Minerva Pediatr; 2020 Aug; 72(4):288-311. PubMed ID: 32418411
[TBL] [Abstract][Full Text] [Related]
11. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
Croze ML; Soulage CO
Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
[TBL] [Abstract][Full Text] [Related]
12. Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Verde L; Camajani E; Cernea S; Frias-Toral E; Lamabadusuriya D; Ceriani F; Savastano S; Colao A; Muscogiuri G
Curr Nutr Rep; 2023 Mar; 12(1):56-64. PubMed ID: 36695999
[TBL] [Abstract][Full Text] [Related]
13. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
Minozzi M; Nordio M; Pajalich R
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
[TBL] [Abstract][Full Text] [Related]
14. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
Regidor PA; Schindler AE; Lesoine B; Druckman R
Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women].
Musacchio MC; Cappelli V; Di Sabatino A; Morgante G; De Leo V
Minerva Ginecol; 2013 Feb; 65(1):89-97. PubMed ID: 23412023
[TBL] [Abstract][Full Text] [Related]
16. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
[TBL] [Abstract][Full Text] [Related]
17. Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents.
Calcaterra V; Cena H; Sottotetti F; Hruby C; Madini N; Zelaschi N; Zuccotti G
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630772
[TBL] [Abstract][Full Text] [Related]
18. Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome.
Cincione RI; Losavio F; Ciolli F; Valenzano A; Cibelli G; Messina G; Polito R
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886216
[TBL] [Abstract][Full Text] [Related]
19. [Myo-inositol in the treatment of polycystic ovary syndrome].
Křepelka P
Ceska Gynekol; 2014 Jun; 79(3):242-6. PubMed ID: 25054962
[TBL] [Abstract][Full Text] [Related]
20. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials.
Mendoza N; Pérez L; Simoncini T; Genazzani A
Reprod Biomed Online; 2017 Nov; 35(5):529-535. PubMed ID: 28756130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
